Fluoxetine: a review of receptor and functional effects and their clinical implications

Psychopharmacology

Volumn 107, Issue 1, 1992, Pages 1-10

  Beasley, Charles M ^a   Masica, Daniel N ^a   Potvin, Janet H ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Antidepressant; Behavior; cAMP; Electrophysiology; Fluoxetine; Neuroendocrine; Receptors; Serotonin

Indexed keywords

ANTIDEPRESSANT AGENT; CYCLIC AMP; FLUOXETINE; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

BEHAVIOR; DRUG EFFECT; DRUG RECEPTOR BINDING; ELECTROPHYSIOLOGY; HUMAN; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVIEW; SEROTONINERGIC TRANSMISSION;

ANIMAL; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; DOWN-REGULATION; ELECTROPHYSIOLOGY; FLUOXETINE; KINETICS; NEUROTRANSMITTER UPTAKE INHIBITORS; RECEPTORS, SEROTONIN; SYNAPTIC TRANSMISSION;

EID: 0026504835     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/BF02244958     Document Type: Review

References (51)

1. Prolonged treatment with the specific 5-HT-uptake inhibitor citalopram: effect on dopaminergic and serotonergic functions
2. Fluoxetine and side effects (letter)
3. Rapid downregulation of beta-adrenoceptors by coadministration of desipramine and fluoxetine
4. The natural history of amine oxidases
5. Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain
6. Decreased beta-adrenergic receptors in rat brain after chronic administration of the selective serotonin uptake inhibitor fluoxetine
7. The effect of chronic antidepressant administration on beta-adrenoceptor function of the beta-adrenoceptor of the rat pineal
8. Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin
9. Fluoxetine subsensitizes a nicotinic mechanism involved in the regulation of core temperature
10. Manipulations of synaptic serotonin: discrepancy of effects on serotonin S1 and S2 sites
11. Intra- and extraneuronal monoamine oxidase
12. Chronic antidepressant treatment and central 5-HT synapses
13. Mechanism of action of antidepressant treatment: implications for the etiology and treatment of depressive disorders
14. Regulation of high- and low-affinity [3H] imipramine recognition sites in rat brain by chronic treatment with antidepressants
15. Acute versus chronic effects of serotonin uptake blockers on potentiation of the serotonin syndrome
16. Effects of chronic fluoxetine administration on serotonin metabolism
17. Adenosine mechanisms are not affected by antidepressant concentrations of desipramine
18. Upregulation of γ-aminobutyric acid (GABA) B binding sites in rat frontal cortex: a common action of repeated administration of different classes of antidepressants and electroshock
19. Differential effects of antidepressant treatment on brain monoaminergic receptors
20. Chronic treatment with antidepressants: potentiation of clonidine-induced aggression in mice via noradrenergic mechanism
21. Chronic and acute administration of typical and atypical antidepressants on activity of brain noradrenaline systems in the rat thiopentone anesthesia model
22. Chronic antidepressant treatment enhances alpha-adrenergic and serotonergic responses in the facial nucleus
23. Role of serotonin reuptake inhibition in the development of subsensitivity of the norepinephrine (NE) receptor coupled adenylate cyclase system
24. Subsensitivity of the norepinephrine receptor-coupled adenylate cyclase system in brain: effects of nisoxetine versus fluoxetine
25. The noradrenalin receptor coupled adrenylate cyclase system in brain: lack of modification by changes in availability of serotonin
26. Age, neuro-psychiatric diseases and brain monoamine oxidase
27. Serotonin receptors
28. Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding
29. The role of alpha2-adrenoceptors in the mechanism of action of antidepressant drugs
30. Antidepressant administration has a differential effect on rat brain alpha2-adrenoceptor sensitivity to agonists and antagonists
31. Relation between brain 5-HIAA levels and the release of serotonin into brain synapses
32. Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro
33. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake
34. Distribution of the two forms of monoamine oxidase within monoaminergic neurons of the guinea pig brain
35. Differential effects of monoamine oxidase inhibitors and serotonin reuptake inhibitors on3H-serotonin receptor binding in rat brain
36. Monoamine oxidase inhibitors and serotonin uptake inhibitors: differential effects on [3H]-serotonin binding sites in rat brain
37. Norepinephrine-stimulated cyclic AMP accumulation in brain slices in vitro after serotonin depletion or chronic administration of selective amine reuptake inhibitors
38. A possible role of serotonin receptors in antidepressant drug action
39. Behavioral evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine
40. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder
41. Effect of chronic antidepressant treatment and subsequent withdrawal of [3H]-5-hydroxytryptamine and [3H]-spiperone binding in rat frontal cortex and serotonin receptor mediated behaviour
42. The inability of chronic fluoxetine to potentiate a serotonin mediated effect
43. Biochemical aspects of monoamine oxidase
44. Receptor alterations associated with serotonergic agents: an autoradiographic analysis
45. Antagonism by antidepressants of serotonin S1 and S2 receptors of normal human brain in vitro
46. Autoradiographic quantification of serotonin1A receptors in rat brain following antidepressant drug treatment
47. Fixed-dose fluoxetine therapy for depression
48. Low-dose fluoxetine therapy for depression
49. Subsensitivity of serotonin receptors after long-term treatment of rats with fluoxetine
50. Chronic effects of fluoxetine, a selective inhibitor of serotonin uptake, on neurotransmitter receptors
51. Reduction of food consumption and body weight of normal and obese mice by chronic treatment with fluoxetine: a serotonin reuptake inhibitor